Preeclampsia is a pregnancy induced hypertensive disease with an incidence of about 5% in primigravida and it significantly contributes to maternal and neonatal morbidity and mortality. The primary cause remains unknown but might be immunologic. Our previous studies have shown that complement neutrophils and macrophages are activated in preeclampsia. The present study evaluated whether the extension of the macrophage, the neutrophil and the complement activation is related to the severity of preeclampsia. Patients with severe preeclampsia. complicated by the syndrome of hemolysis. elevated liver enzymes and low platelet count (HELLP) and women with preeclampsia were studied. Women with uncomplicated pregnancies were controls. To detect activation of macrophages and polymorphonuclear neutrophils (PMN), respectively. the formations of neopterin and PMN elastase were analyzed. For evaluation of complement activation. the biologically active components C5a and the terminal C5b-9 complement complex (TCC) were determined in plasma. Patients with the HELLP syndrome had significantly elevated plasma concentrations of neopterin and C5a at delivery compared to women with preeclampsia. and compared to the controls, the HELLP group had significantly raised plasma levels of neopterin. PMN elastase. C5a and TCe. Women with preeclampsia had significantly higher plasma concentrations of neopterin and TeC at delivery as compared to the controls. In preeclamptics and HELLP patient'!, the plasma concentrations at delivery of PMN elastase, C5a and TCC were normalized within one week. but the plasma levels of neopterin remained elevated after one week. Neopterin, PMN elastase. C5a an<\. TCC are raised in women with severe preeclampsia complicated b y the HELLP syndrome. Monitoring of patients with preeclampsia hy plasma concentrations of these parameters might therefore be helpful in predicting complications of the disease. According to the results of this study. neopterin might he the most sensible plasma parameter to follow.
Introduction
Preeclampsia is a pregnancy induced hypel1ensive disease with an incidence of about 5% in primigravida and. being common .. it significantly contributes to maternal and neonatal morbidity and mortality (I). The primary cause remains unknown but im- § Author to whom correspondence should he addressed.
Ptcridi nes / Vol. 4 / No.:I munologic aherrations are described in preeclampsia such as depressed serum immunoglobulin G , circulating immune complexes and complement activation (2). Vasospasm and endothelial damage arc of fundamental importance in the process of preeclampsia and release of vasoactive substances such as the anaphylatoxins (C3a and C5a) and the terminal C5b-9 complement complex have been described in preeclampsia (3) . C5a can activate neutrophils and is a chemotactic factor for leukocytes. When activated neutrophils attach to the vessel wall a number of prophlogistic substances, able to mediate vascular c1amage, arc released. Activation of neutrophils and ·llacrophages. showed by increased plasma levels of PMN elastase and neopterin, respectively, has been rc"ported in preeclampsia (4, S) . Complement activat-;?J neutrophils release lysosomal enzymes and free n,:ygcn radicals (6) . Increased levels of thromboxane have been descrihed in preeclamptic patients (7) . Ihromboxane A2, a prostaglandin with potent vaso-,'onstrictive and platelet aggregating properties, is primarily derived from platelets, but macrophages ,:bo produce thromboxane. Terminal C5b-9 comple-~;
?nt complex stimulates macrophages and human . ,Jrdcts to synthesize thromboxane (8). CSa and . nllinal CSb-9 complement complex can activate ',dcrophagcs and induce release of potent mono-. \le-derived cytokines such as interleukin-I and inter-.'llkin-6 (~-IO).
The aim of this study was to determine whether :ile extension of the macrophage, the neutrophil and the complement activation is related to the severity )t" preeclampsia.
\ laterials and Methods
Eight consllcutive women with HELLP syndrome
.: Ild eight consecutive women with preeclampsia \\"ilhout any signs of organ dysfunction were studied. Eight consecutivc prcgnant women with uncompli-" aled pregnancies were studied as a control group. 111 all three groups plasma samples were collected .11 the time of delivery, 24 hours after and 7 days ,tlkr delivery. Thc syndrome of hemolysis, elevated liver enzymes and low platelet count (HELLP). was defined as severe preeclampsia concomitant with the following laboratory criteria: hemoglobin levels below 100 giL and bilimbin levels in semm above 21 f.1l1101/L and/ or free hemoglobin in plasma exceeding 20 mglL with the liver enzymes aspartate aminotransferase (ASAT) and alanine aminotransferase (ALAT) exceeding 2.1 Ilkat/ I and platelet count below IOOX IOY/ L (II). The criteria for preeclampsia were a diastolic blood pressure >90 mmHg and proteinuria >0.3 giL in a 24-hour urine sample. and the criteria for severe preeclampsia a diastolic blood pressure > 110 mmHg and proteinuria >0.3 giL in a 24-hour urine sample. All patients had a urine production exceeding lOOO inL per 24 hours, except one who had anuria. All preeclamptic women had normal previous medical histories and were normotensive before and during their first 24 weeks of pregnancy. Five of the eight patients with HELLP syndrome and four of the eight preeclamptic patients were delivered by cesarean section, All normal pregnant women had vaginal deliveries. A previous study has shown that the way of delivery does not affect plasma concentrations of neopterin, PMN elastase, CSa or the terminal CSb-9 complement complex (S).
Peripheral venous blood samples for neoptelin, PMN elastase and complement determinations were drawn into tubes containing ethylene diamine tetraacetic acid (EDTA). The tubes were centrifuged to remove the cells. The plasma samples were frozen within 30 minutes in individual tubes for each determination and stored at -80t until the analyses were performed. All assays were run in duplicates . All samples were analyzed immediately after thawing and no samples were refrozen .
Plasma levels of neopterin were measured to assess activation of macrophages. Neopterin. as 7.~-di hydroneopterin triphosphate. was determined with a RIA-method (Henning Berlin GMBH. Berlin. Germany), described by Rokos and Rokos (1983) (12) . All results are give as means of duplicate determinations.
Formation of PMN elastase in plasma to evaluate activation of neutrophils was analyzed. PMN elastase. determined as polymorphonuclear elastase complexed with alphalproteinase inhibitor. was measured by the PMN Elastase IMAC® immunoassay (E. Merck. Darmstadt. Germany) as modified by Dreher and coworkers (13. 14) . Antisera against PMN elastase are raised in sheep and have been shown to be antigen-specific by immunoelectrophoresis (IS). Cross-reactivity has been excluded between the PMN elastase and the elastase deIived from platelets or pancreas or other granulocyte lysosomal proteins (16) . The quantitations were obtained in duplicates and the results are means of the duplicate detemlinations.
To detect complement activation, the levels of the complement split product CSa and the terminal CS h-9 complement complex were determined in plasma. The concentration of CSa antigen was analyzed by a radioimmunoassay (RIA) described by Hugli and Chenoweth (17) and the temliilal CSh-9 complement complex was determined with a double antibody enzymelinked immunosorbent assay (ELISA) according to Mollnes et al. (18) The results are all given as means of duplicate determinations.
Mean values and standard errors of the mean (SEM) were calculated with standard methods. The Wilcoxon rank sum test was used tor statistical analysis of differences between the groups. Differences were considered significant when p< .05.
Results
In Table I the clinical variables are presented for the HELLP group, the preeclamptics and the women with uncomplicated pregnancies as mean values and SEM. There were no significant differences between the three groups regarding age, paIity a nd blood pressure before gestational week 24. Regarding the blood pressure at delivery, it was raised in the HELLP group as compared to both the preeclamptics (P<'05) and the controls (p<J)OI), and the preeclamptic group had higher blood pressure at delivery as compared to the uncomplicated group (P<.OI). All HELLP patients and preeclamptic women had proteinuria, in the mean amounts of 7.6± 4.4 gil and 3.5± 1.2 gil, respectively. None of the women with uncomplicated pregnancies had proteinuria. There was no significant difference between the HELLP group and the preeclamptic group regarding the degree of proteinuria. The HELLP patients and the preeclamptic women had lower birth weight (P<.05) as compared to the controls. but the birth weight did not differ significantly between the patients with HELLP and the preeclamptics. The gestational age was lower in the HELLP group as compared to the controls (P<.05), but did not differ significantly between the preeclamptics and the HELLP group or between the preeclamptic group and the uncomplicated pregnant women.
In Table 2 the laboratory values are given for the HELLP patients. the women with preeclampsia and group of women with uncomplicated pregnancies as mean values and SEM. Hemoglobin levels were lower in the HELLP group as well compared to the controls (P<.OOI) as to the preeclamptics (P<. 05), but did not differ between the preeclamptic group and the uncomplicated pregnancies. Aspartate aminotroansferase were higher in the HELLP patients when compared to the controls (P< .OOI) as well as to the preeclamptics (P< .OOI), but did not differ between the women with preeclampsia and the uncomplicated group. Alanine aminotransferase was greater among the women with HELLP as compared do both the controls (P<.Ol) and the preeclamptics (P<.OI). but did not differ between the preeclamptic patients and the uncomplicated pregnancies. The platelet counts were lower in the HE-LLP group as well compared to the women with uncomplicated pregna ncies (P<.OOI) as to those with preeclampsia (P<.OI). The platelet counts were also decreas~d among preeclamptic women compared to controls (P<.05). The creatinine levels were higher in the HELLP group than in the controls (P< .O I) and also than in the preeclamptics (P<.05). The creatinine concentrations were raised among women with preeclampsia as compared to women with uncomplicated pregnancies (P<.OI). The urate levels were greater in the HELLP group than in normals (P<.OI). but not compared to pr~eclamptics. Concentrations of urate were raised in the preeclamptic group as compared to the uncomplicated pregna ncies (P<.OI).
The plasma levels of neopterin, PMN elastase and the complement vaIiables, at delivery and one and seven days after delivery are given in Table 3 . The plasma concentrations of neopterin were elevated in the HELLP group at delivery (P< .OOI), 1 day Table 3 . The significances for the differences regarding I and 7 clays after delivery are given in the text. HELLP and normals, *=p<O.05, ** = p<O.OL *** = p < OJ)Ol: HELLP and preeclamptics. # # = p<O.OL • H = p<O.OOI: Preeclamptics and normals, 0 = p < 0.05. " = No rmal levels in healthy nonpregnant volunteers.
after delivery (P<.OI) and 7 days after delivery (P< . 0 1) as compared to the normal pregn ant group. The neoptenn levels among the HELLP patients were greater than in the preeclamptic group at delivery (P<.OOI) and 1 day after delivery. The neopterin concentrations in the preeclamptics as compared to the controls were raised at delivery (P<.05) and 7 days after delivery (P<.05). The plasma levels of PMN elastase in the HELLP group were higher than in the women with uncomplicated pregnancies at delivery (P<.05) and 1 day after delivery (P<.05). No significant differences regarding the plasma levels of PMN elastase were found when the preeclamptics were compared to controls or to the H ELLP patients. The p lasma concentrations of C5a were increased at delivery (P< .Ol ), I day after (P<.05) delivery and 7 days after delivery (P< .05) in HELLP patients as compared to controls. The plasma levels of C5a were higher in the HELLP group as compared to women with preeclampsia at del ivery (P<.Ol) and seven days after delivery (P<.05). No significant differences werc found regarding the concentrations of C5a when the preeclamptic group were compared with the controls. Terminal C5b-9 complement complex levels in plasma were higher in the HELLP group at deliveIY (P < .OOl) and I day after delivery (P<.O I) than in women with uncomplicated pregnancies. Plasma concentrations of terminal C5b-9 com-piement complex in the preeclamptic women were raised as compared to the uncomplicated pregnant group at delivery (P< .OS). No differences regarding the concentrations of tenninal CSb-9 complement complex were seen when the HELLP patients were compared to the preeclamptic group.
Discussion
Macrophages. neutrophils and the complement system are activated in severe preeclampsia with multiple organ dysfunction. Indicated by raised plasma levels of neopterin, PMN clastase, C5a and the tenninal C5b-9 complement complex in the patients with HELLP syndrome at the time of delivery. Maerophages and the complement system are activated in patients with preeclampsia without organ dysfunction in this study. Indicated by increased plasma eoncentations of neopterin and terminal CSb-9 complement complex in preeclamptic patients at the time of delivery. Neutrophil activation as increased plasma levels of PMN elastase has earlier heen reported for preeclamptic patients without organ dysfunction (4), also increased CSa concentrations in plasma has been described in these patients (3). It seems possihle to differ uncomplicated pregnancies from various preeclamptic pregnancies using the inflammatory parameters neopterin, PMN elastase. CS a and tenninal complement complex. The present study was aimed to evaluate whether the extension of the macrophage. the neutrophil and the complement activation is related to the severity of preeclampsia. and according to results it also seems possible to differentiate preeclampsia with and without organ dysfunction using plasma concentrations of neopterin and CSa. This is indicated by increased plasma level of neopterin and CSa in patients with HELLP syndrome as compared to women with preeclampsia at the time of delivery.
Neoptel;n and PMN elastase has previously heen described in patients with sepsis and trauma to he useful parameters for diagnosis and monitoring in association with multiple organ failure, indicating the possihle central role of macrophage and neutrophil activation in the development of multiple organ failure (19) . Increased neopterin excretion has also been registered in acute cell mediated graft rejection (20) . The pathophysiology of severe preeclampsia might he explained as a whole hody inflammatory reaction on the basis of a partial rejection of the fetal tissue. since macrophage, neutrophil and complement activation, cytokine release and increased amounts of natural killer cells have been demonstPteridines / Vol. 4 / No. 3 rated in this disease (21) (22) (23) . Earlier data on complement activation indicate that the degree of complement activation follow the severity of disease in pancreatitis and sepsis and the extent and the severity of the complications to trauma and ischemia (24. 2S) . Plasma levels of C3a have heen shown to correlate positively to the severity of pancreatitis. sepsis and burn injury, while raised concentrations of CSa were more irregularly found (24) (25) (26) . DifTerences in the turnover of C3a and CSa within the body make it easier to demonstrate raised concentrations of C3a than C5a in plasma. Increased C5a concentrations are f()Und in plasma only when the neutrophil hinding capacity is exceeded. The generation of terminal CSb-9 complement complex indicates. however, that the terminal paI1 of the complement cascade has been activated and that C5a has been released but eliminated. Taking the above mentioned in consideration. a further evaluation of the use of neopterin, PMN elastase. CSa and terminal CSh-9 complement complex plasma concentrations in severe preeclampsia might be relevant as parameters of illness/ treatment in fulminant preeclampsia, where leukocyte activation and complement activation may have a substantial part in the pathophysiologic mechanisms. The only definite cure of preeclampsia so far has been delivel),. even in early pregnancy. with fatal consequences for the fetus. The main problem has been the lack of safe monitoring of women with severe preeclampsia in early pregnancy. gestational week 24 to 30. in order to predict lethal/serious deterioration in the maternal cWldition, may be leading to prompt deliveries in too many cases. The problem is delicate, hut safe monitoring of women with severe preeclampsia is an essential issue in obstetrics and intensive care medicine. Even if this study indicated that neopterin could be the most sensihle plasma parameter to follow. none of the studied parameters could he excluded at this early stage. The studied groups were small and the variations within the groups were large.
Microvascular injury occurs in different organs in preeclampsia (27). One possible pathophysiologic explanation tor the microvascular injuries might be complement-induced activation of neutrophils and macrophages (S, 28, 29) with the release of biologically active and potent inf1ammatory mediators. The complexity of the manifestations of preeclampsia needs to he further studied. That inflammatory mechanisms have a role in the pathophysiology of severe preeclampsia is tempting to suggest since macrophage, neutrophil and complement activation have been demonstrated in this disease.
